Understanding and improving treatments for Sjögren’s Disease
Sjögren’s Team for Accelerating Medicines Partnership (STAMP)
This study is looking for people with Sjögren’s Disease to help us learn more about the condition and find better ways to diagnose and treat it, so your participation can make a real difference!
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-11012852 on NIH RePORTER |
What this research studies
This research focuses on Sjögren’s Disease, a common autoimmune disorder that affects the glands responsible for saliva and tears. The project aims to gather a large group of patients with Sjögren’s Disease to better understand the disease mechanisms and improve diagnosis and treatment options. By utilizing a multidisciplinary approach, the research team will collect detailed patient information and biological samples to identify potential new therapies. Patients will be actively involved in the research process, contributing to a deeper understanding of their condition.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Sjögren’s Disease, particularly those experiencing significant symptoms or complications.
Not a fit: Patients with other autoimmune disorders that do not involve Sjögren’s Disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved diagnostic methods and new treatment options for patients with Sjögren’s Disease.
How similar studies have performed: Previous research in autoimmune diseases has shown promise in using similar multidisciplinary approaches to enhance understanding and treatment options.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Shiboski, Caroline Helene — University of California, San Francisco
- Study coordinator: Shiboski, Caroline Helene
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.